6533b82efe1ef96bd129279a
RESEARCH PRODUCT
Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immune checkpoint inhibitors for first- or second-line treatment of advanced gastric and gastro-esophageal junction cancer
Berna C. ÖZdemirNicholas SynBee Choo TaiMarkus MoehlerAnna Dorothea Wagnersubject
Medicine General & Introductory Medical SciencesChemotherapySecond line treatmentbusiness.industrymedicine.medical_treatmentImmune checkpoint inhibitorsCancer researchGastro esophageal junctionmedicineCancerPharmacology (medical)businessmedicine.diseasedescription
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the efficacy and safety of immune checkpoint inhibitors, alone or in combination with chemotherapy, in people with advanced gastric and gastroesophageal junction adenocarcinoma in first and subsequent treatment lines.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2019-07-03 | Cochrane Database of Systematic Reviews |